AM
Ahmed Musa

Publications (7)

The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities
Article scientifique · 2025
Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to- moderate COVID-19 patients in sub-Saharan Africa
Article scientifique · 2025
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform
Article scientifique · 2024
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study
Article scientifique · 2023
Active circulation of varicella zoster virus among different age groups in Sudan
Article scientifique · 2022
Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis
Article scientifique · 2018
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial
Article scientifique · 2016

Domaines principaux

Sciences de la santé7

Statistiques

Consultations14
Téléchargements0